The UC Davis MIND Institute's annual trunk-or-treat event drew hundreds of families last weekend. The free, public event is geared toward individuals with autism, fragile X syndrome, Down syndrome and other neurodevelopmental conditions.
Two sisters are receiving a breakthrough, FDA-approved treatment for beta thalassemia at UCSF Benioff Children's Hospital, Oakland. This is the first real therapy other than monthly transfusions for a devastating disease that destines people to shorter lives.
A study by endocrinology researchers shows a high prevalence of thyroid cancer among transgender female veterans, the first evidence of such a disparity.
Laura Esserman discusses breast cancer risk factors, progress in the field and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
UC Davis researchers identified a crucial mechanism that can cause cells to self-destruct. This new ability to trigger cell death could open the door for improved cancer treatments.
UC Davis Health researchers are part of a global study to determine whether giving stroke patients a high dose of a natural protein can improve stroke recovery.
Health Media Contacts
Find the best contact for health-related media inquiries.
